These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 17562493)

  • 1. Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with lorazepam.
    Herrera-Arellano A; Jiménez-Ferrer E; Zamilpa A; Morales-Valdéz M; García-Valencia CE; Tortoriello J
    Planta Med; 2007 Jul; 73(8):713-7. PubMed ID: 17562493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effectiveness of Galphimia glauca vs. lorazepam in generalized anxiety disorder. A controlled 15-week clinical trial.
    Herrera-Arellano A; Jiménez-Ferrer JE; Zamilpa A; García-Alonso G; Herrera-Alvarez S; Tortoriello J
    Planta Med; 2012 Sep; 78(14):1529-35. PubMed ID: 22828921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
    Cutler NR; Sramek JJ; Wardle TS; Hesselink JM; Roeschen JK
    Psychopharmacol Bull; 1993; 29(2):303-8. PubMed ID: 7904761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial.
    Herrera-Arellano A; Miranda-Sánchez J; Avila-Castro P; Herrera-Alvarez S; Jiménez-Ferrer JE; Zamilpa A; Román-Ramos R; Ponce-Monter H; Tortoriello J
    Planta Med; 2007 Jan; 73(1):6-12. PubMed ID: 17315307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study.
    Andreatini R; Sartori VA; Seabra ML; Leite JR
    Phytother Res; 2002 Nov; 16(7):650-4. PubMed ID: 12410546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial.
    Gastpar M; Klimm HD
    Phytomedicine; 2003 Nov; 10(8):631-9. PubMed ID: 14692723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical assessment of the safety and efficacy of lorazepam, a new benzodiazepine derivative, in the treatment of anxiety.
    Pinosky DG
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):24-9. PubMed ID: 30763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice.
    Nguyen N; Fakra E; Pradel V; Jouve E; Alquier C; Le Guern ME; Micallef J; Blin O
    Hum Psychopharmacol; 2006 Apr; 21(3):139-49. PubMed ID: 16625522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galphimine-B Standardized Extract versus Alprazolam in Patients with Generalized Anxiety Disorder: A Ten-Week, Double-Blind, Randomized Clinical Trial.
    Romero-Cerecero O; Islas-Garduño AL; Zamilpa A; Herrera-Arellano A; Jiménez-Ferrer E; Tortoriello J
    Biomed Res Int; 2019; 2019():1037036. PubMed ID: 30834253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder.
    Woelk H; Schläfke S
    Phytomedicine; 2010 Feb; 17(2):94-9. PubMed ID: 19962288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and mycological evaluation of therapeutic effectiveness of Solanum chrysotrichum standardized extract on patients with Pityriasis capitis (dandruff). A double blind and randomized clinical trial controlled with ketoconazole.
    Herrera-Arellano A; Jiménez-Ferrer E; Vega-Pimentel AM; Martínez-Rivera Mde L; Hernández-Hernández M; Zamilpa A; Tortoriello J
    Planta Med; 2004 Jun; 70(6):483-8. PubMed ID: 15241887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
    Cohn JB; Wilcox CS
    J Clin Psychiatry; 1986 Aug; 47(8):409-12. PubMed ID: 2874128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic and antidepressant-like activity of a standardized extract from Galphimia glauca.
    Herrera-Ruiz M; Jiménez-Ferrer JE; De Lima TC; Avilés-Montes D; Pérez-García D; González-Cortazar M; Tortoriello J
    Phytomedicine; 2006 Jan; 13(1-2):23-8. PubMed ID: 16360929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
    Pollack MH; Tiller J; Xie F; Trivedi MH
    J Clin Psychopharmacol; 2008 Jun; 28(3):308-16. PubMed ID: 18480688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical comparison between alprazolam and lorazepam. A polycentric study in double blind].
    Botte L; Bienfait J; Dethier J; Even P; Evrard JL; Fraipont J; Goffin L; Willemse P
    Acta Psychiatr Belg; 1981; 81(6):595-608. PubMed ID: 6125089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pollinosis therapy with Galphimia glauca].
    Wiesenauer M; Häussler S; Gaus W
    Fortschr Med; 1983 May; 101(17):811-4. PubMed ID: 6345308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial.
    Volz HP; Kieser M
    Pharmacopsychiatry; 1997 Jan; 30(1):1-5. PubMed ID: 9065962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.